Anderson Hoagland & CO Heska Corp Transaction History

Anderson Hoagland & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	BUY	$72.92 - $99.73 $63,002 - $86,166	864 Added 7.0%	13,207 $963,000
Q1 2022 Apr 12, 2022	SELL	$122.89 - $171.74 $13,517 - $18,891	-110 Reduced 0.88%	12,343 $1.71 Million
Q4 2021 Jan 25, 2022	SELL	$156.0 - $265.78 $43,836 - $74,684	-281 Reduced 2.21%	12,453 $1.91 Million
Q3 2021 Oct 07, 2021	SELL	$228.69 - $274.2 $27,671 - $33,178	-121 Reduced 0.94%	12,734 $3.29 Million
Q2 2021 Jul 19, 2021	BUY	$169.89 - $231.37 $748,705 - $1.02 Million	4,407 Added 52.17%	12,855 $2.95 Million
Q1 2021 Apr 09, 2021	BUY	$143.93 - $207.3 $1.22 Million - $1.75 Million	8,448 New	8,448 $1.42 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Anderson Hoagland & CO, based on Form 13F filings with the SEC.

Stay updated on Anderson Hoagland & CO with notifications on news.